These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6418077)

  • 1. [Clinical analysis on side effects of long-term oral administration of futraful to out-patients].
    Soejima S; Kako N; Kawaguchi T; Kimura Y; Soga S; Nomura S; Okouchi Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2516-22. PubMed ID: 6418077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
    Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant chemotherapy for gastric cancer--relation between long-term administration of FT-207 and prognosis].
    Tanaka T; Inaba S; Naito K; Iguchi K; Yamagishi H; Kobayashi M
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):130-7. PubMed ID: 6421240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of therapeutic and toxic doses of levamisole on thyroid hormones and some biochemical parameters in sheep.
    Atessahin A; Karahan I; Pirincci I
    Cell Biochem Funct; 2004; 22(5):281-6. PubMed ID: 15338466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic effects of prolonged oral administration of tegafur (FT-207)].
    Majima H; Nishimura A
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):726-32. PubMed ID: 7184423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of futraful suppositories in malignant head and neck cancer--effects of the therapy combined with radiation].
    Tomioka M; Usami M; Sakamoto A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1374-9. PubMed ID: 6820914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined administration of futraful and esquinone for the treatment of advanced ovarian cancer].
    Inoue S; Fukuda O; Tajima C; Tokunaga T; Nakayama M; Maeyama M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1226-30. PubMed ID: 6820911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Futraful therapy on liver cancer.
    Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Ariyama J
    Clin Oncol; 1977 Mar; 3(1):33-49. PubMed ID: 193664
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the behavior of serum enzymes LDH, GOT and GPT in tumors and the possibility of diagnostic and prognostic conclusions].
    Buchelt L; Hess F
    Strahlentherapie; 1968 Nov; 136(5):574-80. PubMed ID: 5708883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cooperative phase II study of spansule tegafur (SF-SP)].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of orally and rectally administered Tegafur in liver metastases from gastric carcinoma.
    Reyes JM; Okazaki N; Yoshino M; Yoshida T
    Jpn J Clin Oncol; 1984 Mar; 14(1):41-7. PubMed ID: 6423866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anosmia or hyposmia after long-term oral administration of tegafur--improved anosmia].
    Majima H; Aoki H; Sugenoya H; Shirai O; Toyoda B
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2128-33. PubMed ID: 3087292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublethal effects of hexavalent chromium on the body growth rate and liver function enzymes of phenobarbitone-pretreated and promethazine-pretreated rabbits.
    Anjum F; Shakoori AR
    J Environ Pathol Toxicol Oncol; 1997; 16(1):51-9. PubMed ID: 9256933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.